Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Personalized Genomics Market Grown from 2024 to 2025?

In the recent past, the market size for personalized genomics has seen a significant rise. It is projected to escalate from $8.15 billion in 2024 to $9.45 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 16.0%. This remarkable growth during the historical period can be credited to the increased awareness about genetic risk elements among the public at large, the escalating incidence of chronic and genetic illnesses, the expanding incorporation of AI and machine learning in genomic study, the surging demand for nutrigenomics and genomics centered on lifestyle, along with an increasing emphasis on companion diagnostics in the fields of oncology and rare diseases.

What Growth Rate Is Anticipated for the Personalized Genomics Market in the Coming Years?

The size of the personalized genomics market is predicted to expand at a quick pace in the following years. By 2029, it is projected to reach $16.97 billion, with a compound annual growth rate (CAGR) of 15.8%. The forecast period expansion is due to an increased demand for tailor-made medicine, higher consumer interest in direct-to-consumer genetic testing, a rising trend towards preventative health methods, growing access to genomic data and bioinformatics tools, as well as a surge in partnerships between pharmaceutical and genomics companies. The key trends for the projection period consist of advancements in next-generation sequencing technologies, incorporating artificial intelligence in genomic data interpretation, combining genomics with electronic health records, improvements in bioinformatics platforms, and creating cloud-centric systems for storing and sharing genomic data.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24654&type=smp

Who Are the Leading Companies in the Personalized Genomics Market?

Major companies operating in the personalized genomics market are Thermo Fisher Scientific Inc., Illumina Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Invitae Corporation, Guardant Health Inc., GeneDx LLC, Ancestry Inc., Oxford Nanopore Technologies plc, Genomic Health Inc., 23andMe Holding Co., Color Health Inc., Helix OpCo LLC, Personalis Inc., Dante Genomics, Gene By Gene Ltd., Veritas Genetics Inc., Futura Genetics, Nebula Genomics Inc., Pathway Genomics Corporation

What Are the Key Drivers of the Personalized Genomics Market?

The growth of the personalized genomics market is anticipated to be driven by the increasing prevalence of chronic and rare diseases. Chronic diseases necessitate continuous management because they are enduring conditions, while rare diseases, which affect a small portion of the population and often need specialized care, are less common. The surge in these diseases can also be traced back to lifestyle choices, for example, an unhealthy diet, inadequate exercise, and exposure to harmful environmental factors, which all play a part in the onset of various conditions. Personalized genomics facilitates the management of these diseases by devising treatments based on each person’s genetic profile, which leads to more exact diagnoses, more optimally targeted treatments, and better handling of conditions that may be due to specific genetic factors or risks. For example, the National Center for Biotechnology Information, a US-based medical library, stated in January 2023 that there is projected to be a 99.5% rise in the number of people with at least one chronic disease, increasing from 71.522 million in 2020 to 142.66 million by 2050. Consequently, the increased prevalence of chronic and rare diseases is propelling the growth of the personalized genomics market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24654&type=smp

What Are the Key Market Segments in the Personalized Genomics Industry?

The personalized genomics market covered in this report is segmented –

1) By Test Type: Oncology Testing, Infectious Disease Testing, Neurological Testing, Cardiovascular Testing, Other Test Types

2) By Technology: Polymerase Chain Reaction-Based Tests, Microarray-Based Tests, Sequencing-Based Tests, Other Technologies

3) By Application: Diagnostics, Precision Medicine, Wellness, Reproductive Health, Sports Nutrition And Health, Lifestyle, Other Applications

4) By End User: Hospitals And Clinics, Research Centers, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Other End Users

Subsegments:

1) By Oncology Testing: Liquid Biopsy, Tumor Profiling, Genetic Testing For Cancer Risk, Companion Diagnostics

2) By Infectious Disease Testing: Hepatitis Testing, COVID-19 Testing, Respiratory Infections Testing, Sexually Transmitted Infections Testing

3) By Neurological Testing: Alzheimer’s Disease Testing, Huntington’s Disease Testing, Parkinson’s Disease Testing, Epilepsy Testing

4) By Cardiovascular Testing: Genetic Risk for Cardiovascular Diseases, Arrhythmia Testing, Lipid Panel Testing, Coronary Artery Disease Testing

5) By Other Test Types: Pharmacogenomics Testing, Genetic Screening For Inherited Disorders, Paternity Testing, Ancestry Testing

What Are the Latest Trends in the Personalized Genomics Market?

Leading businesses in the personalized genomics market are concentrating on the advancement of novel technologies such as personalized genomics platforms. These platforms are designed to deliver personalized insights concerning health, wellness, and disease prevention by analysing a person’s genetic data. To illustrate, Neuberg Diagnostics Private Limited, a diagnostic service company based in India, launched a new bespoke genomics platform, Geniee Decode Your DNA, in September 2024. This platform provides customised health, nutrition, and medication advice based on an individual’s genetic make-up. It aims to enhance wellness, avert diseases, and tailor treatments for improved health results.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-genomics-global-market-report

What Are the Key Regional Markets in the Personalized Genomics Industry?

North America was the largest region in the personalized genomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized genomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24654

This Report Delivers Insight On:

1. How big is the personalized genomics market, and how is it changing globally?

2. Who are the major companies in the personalized genomics market, and how are they performing?

3. What are the key opportunities and risks in the personalized genomics market right now?

4. Which products or customer segments are growing the most in the personalized genomics market?

5. What factors are helping or slowing down the growth of the personalized genomics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model